Marshall Wace
VTVT icon

Marshall Wace’s vTv Therapeutics VTVT Stock Holding History

Marshall Wace’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$531K Buy
+13,389
New +$486K ﹤0.01% 2421
2021
Q4 		– Sell
-585
Closed -$36K – 4313
2021
Q3 		$36K Sell
585
-6,221
-91% -$469K ﹤0.01% 2944
2021
Q2 		$621K Buy
6,806
+2,381
+54% +$241K ﹤0.01% 2039
2021
Q1 		$499K Buy
+4,425
New +$435K ﹤0.01% 1943

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Marshall Wace's VTVT Position: Q1 2026 in Review

Marshall Wace opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 13,389 shares worth $531K. The stake represents ﹤0.01% of the portfolio and ranks #2421 among its holdings. This is a return to the name: Marshall Wace previously reported a position in VTVT as recently as Q3 2021.

Marshall Wace first reported a position in VTVT in Q1 2021 and has held it in 4 quarters since. The position peaked at $621K in Q2 2021. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Marshall Wace held 13,389 shares of vTv Therapeutics worth $531K as of Q1 2026.
  • vTv Therapeutics was a new Marshall Wace position in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2421 holding.
  • Marshall Wace first reported a position in vTv Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Marshall Wace's vTv Therapeutics position peaked at $621K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.